(Q73377531)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

M Yoshikawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Sakuma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Hibino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Sato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Fujinami

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

published in

Clinical Biochemistry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

221-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Enhanced macrophage degradation of biologically modified low density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Distribution, fatty acid composition and apolipoprotein A-I immunoreactivity of high density lipoprotein subfractions in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

High density lipoprotein is a scavenger of superoxide anions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

HDL, its enzymes and its potential to influence lipid peroxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Changes of HDL subfraction concentration and particle size by intralipid in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Antioxidative activity of high density lipoproteins in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Measurement of protein using bicinchoninic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Biochemical, structural, and functional properties of oxidized low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900031-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9120(97)00031-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9167898%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference